Fortis Healthcare Reports Strong Financial Performance Amid Rising Debt Concerns in June 2025

Aug 07 2025 08:53 AM IST
share
Share Via
Fortis Healthcare has announced its financial results for the quarter ending June 2025, reporting a significant increase in Profit After Tax at Rs 250.67 crore and net sales of Rs 2,166.72 crore. Operating profit also reached a five-quarter high, while rising interest expenses and a higher debt-equity ratio present challenges.
Fortis Healthcare has recently reported its financial results for the quarter ending June 2025, showcasing a notable performance in various key metrics. The company's Profit After Tax (PAT) reached Rs 250.67 crore, marking the highest figure in the last five quarters, indicating a positive trend in profitability. Additionally, net sales also peaked at Rs 2,166.72 crore during the same period, reflecting a strong sales performance.

Operating profit, measured as PBDIT, stood at Rs 490.67 crore, again the highest in the last five quarters, suggesting enhanced operational efficiency. The operating profit margin improved to 22.65%, further highlighting the company's effective management of costs and resources. Profit Before Tax less Other Income (PBT) also reached a record Rs 322.54 crore, growing significantly compared to previous averages.

However, Fortis Healthcare is facing challenges as well. The interest expense has risen to Rs 137.13 crore, indicating increased borrowings, while the debt-equity ratio has reached 0.28 times, suggesting a higher reliance on debt to finance operations. These factors may impact the company's liquidity position.

Overall, Fortis Healthcare has experienced evaluation changes in its financial metrics, reflecting a complex landscape of growth and challenges.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News